Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $2,374,127 (100.0% shares, 0.0% debt)

Holdings (40)

ABIOMED INC 13.7%
Value ($000) $326,292 Shares 1,935,300 Est. Cost $32.04 Unrealized
CLOVIS ONCOLOGY INC 11.6%
Value ($000) $274,357 Shares 3,329,581 Est. Cost $54.10 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value ($000) $226,953 Shares 2,438,519 Est. Cost $79.50 Unrealized +11.2%
UTHR UNITED THERAPEUTICS CORP DEL 8.7%
Value ($000) $206,565 Shares 1,762,650 Est. Cost $88.34 Unrealized +44.6%
INSM INSMED INC 8.1%
Value ($000) $192,622 Shares 6,171,816 Est. Cost $15.01 Unrealized +26.9%
ALEXION PHARMACEUTICALS INC 6.4%
Value ($000) $151,561 Shares 1,080,342 Est. Cost $121.12 Unrealized
EPIZYME INC 5.1%
Value ($000) $121,888 Shares 6,398,296 Est. Cost $15.31 Unrealized
FOLD AMICUS THERAPEUTICS INC 4.7%
Value ($000) $111,898 Shares 7,420,288 Est. Cost $6.23 Unrealized +112.3%
VNDA VANDA PHARMACEUTICALS INC 3.1%
Value ($000) $74,386 Shares 4,155,670 Est. Cost $8.70 Unrealized +92.3%
PRTA PROTHENA CORP PLC 3.0%
Value ($000) $70,966 Shares 1,095,655 Est. Cost $32.98 Unrealized +85.7%
WRIGHT MED GROUP N V 2.9%
Value ($000) $69,238 Shares 2,676,393 Est. Cost $23.44 Unrealized
AMAG PHARMACEUTICALS INC 2.7%
Value ($000) $63,491 Shares 3,441,233 Est. Cost $29.62 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.6%
Value ($000) $61,818 Shares 1,641,030 Est. Cost $29.82 Unrealized +9.1%
SAGE THERAPEUTICS INC 2.1%
Value ($000) $49,046 Shares 787,251 Est. Cost $42.59 Unrealized
STAA STAAR SURGICAL CO 1.8%
Value ($000) $43,663 Shares 3,507,052 Est. Cost $8.00 Unrealized +39.3%
CELGENE CORP 1.8%
Value ($000) $43,052 Shares 295,240 Est. Cost $97.51 Unrealized
IMMUNOMEDICS INC 1.8%
Value ($000) $42,086 Shares 3,010,466 Est. Cost $8.83 Unrealized
ALGN ALIGN TECHNOLOGY INC 1.8%
Value ($000) $41,558 Shares 223,107 Est. Cost $94.04 Unrealized +82.0%
KARYOPHARM THERAPEUTICS INC 1.6%
Value ($000) $38,414 Shares 3,498,585 Est. Cost $19.70 Unrealized
MOMENTA PHARMACEUTICALS INC 1.4%
Value ($000) $33,207 Shares 1,794,998 Est. Cost $14.13 Unrealized
AIMMUNE THERAPEUTICS INC 1.4%
Value ($000) $32,072 Shares 1,293,764 Est. Cost $22.25 Unrealized
EXAS EXACT SCIENCES CORP 0.9%
Value ($000) $20,407 Shares 433,076 Est. Cost $13.61 Unrealized +195.7%
SHIRE PLC 0.8%
Value ($000) $19,939 Shares 130,200 Est. Cost $219.26 Unrealized
GILD GILEAD SCIENCES INC 0.6%
Value ($000) $14,251 Shares 175,900 Est. Cost $62.02 Unrealized -9.8%
BIOVERATIV INC 0.5%
Value ($000) $12,059 Shares 211,300 Est. Cost $57.07 Unrealized
RIGEL PHARMACEUTICALS INC 0.4%
Value ($000) $9,792 Shares 3,855,024 Est. Cost $3.39 Unrealized
ACELRX PHARMACEUTICALS INC 0.2%
Value ($000) $4,750 Shares 1,032,715 Est. Cost $5.54 Unrealized
ALIMERA SCIENCES INC 0.2%
Value ($000) $4,069 Shares 3,013,793 Est. Cost $4.88 Unrealized
DICERNA PHARMACEUTICALS INC 0.1%
Value ($000) $2,880 Shares 500,913 Est. Cost $5.39 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value ($000) $2,255 Shares 1,162,473 Est. Cost $4.37 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value ($000) $1,793 Shares 123,686 Est. Cost $6.71 Unrealized +103.5%
IDERA PHARMACEUTICALS INC 0.1%
Value ($000) $1,374 Shares 616,355 Est. Cost $3.70 Unrealized
CEMPRA INC 0.0%
Value ($000) $1,106 Shares 340,320 Est. Cost $22.71 Unrealized
ZOGENIX INC 0.0%
Value ($000) $1,034 Shares 29,500 Est. Cost $13.36 Unrealized
TREVENA INC 0.0%
Value ($000) $870 Shares 341,300 Est. Cost $2.30 Unrealized
ALDER BIOPHARMACEUTICALS INC 0.0%
Value ($000) $789 Shares 64,400 Est. Cost $12.25 Unrealized
HISTOGENICS CORP 0.0%
Value ($000) $600 Shares 302,922 Est. Cost $11.00 Unrealized
SOPHIRIS BIO INC 0.0%
Value ($000) $530 Shares 247,000 Est. Cost $2.60 Unrealized
ALCOBRA LTD 0.0%
Value ($000) $276 Shares 272,788 Est. Cost $5.98 Unrealized
SOLENO THERAPEUTICS INC 0.0%
Value ($000) $220 Shares 84,748 Est. Cost $0.50 Unrealized